ECTRIMS Research Fellowship in Switzerland 2025_ Fully Funded: (Deadline 1 December, 2024)
INTRODUCTION
The Fully Funded ECTRIMS Research Fellowship in Switzerland is open to all nationals. It is specifically for young neuroscientists, aiming to support their involvement in basic, clinical, or applied research relevant to multiple sclerosis. The main objective of this program is to enhance the sharing of knowledge and contribute to the expansion of the community of research scientists dedicated to addressing challenges in the field of multiple sclerosis. ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) offers this research training fellowship to postdoctoral students. Hence, if you want to become an ECTRIMS fellow, then you must apply for the ECTRIMS Research Fellowship in Switzerland 2024.
In addition, the ECTRIMS Fellowship provides a unique research opportunity where potential fellows will outline a clear basic, clinical, or applied research project. This project will take place during the fellowship period, working closely with a mentor at the host institution. Similarly, the ECTRIMS Research Fellowship Program involves a period spent in a European research laboratory or clinic addressing challenges related to multiple sclerosis. The duration of the ECTRIMS Fellowship Programme is one or two years and is likely to start in June 2025. This opportunity is ideal for individuals seeking a postdoctoral fellowship, especially those looking to pursue research in Europe, with a particular focus on studying in Switzerland. ECTRIMS offers one or two-year funded fellowships to all fellows either in a European lab or clinic. Therefore, the postdoctoral fellowship in Switzerland also provides an annual stipend along with transportation expenses to all its fellows.
Moreover, the ECTRIMS Postdoctoral Research Fellowship Program offers a research-intensive fellowship in which fellows actively participate in annual ECTRIMS congresses throughout their fellowship. Additionally, ECTRIMS fellows will have to deliver a presentation on their funded research. ECTRIMS provides separate support for travel and accommodation for the congress participation. While the primary focus of the ECTRIMS Fellowship is on research activities, fellows have the flexibility to allocate up to 10% of their time to teaching or clinical care that is not directly tied to a research project or additional coursework.
BENEFITS
The benefits of the Fully Funded ECTRIMS Research Fellowship in Switzerland are:
- The ECTRIMS postdoc fellowship offers each fellow an annual stipend of 55,000 EUR.
- ECTRIMS will also cover economy transportation expenses from the fellow’s home location to the training city and back. Reimbursement for transportation costs will be given directly to the fellow upon the submission of receipts to ECTRIMS.
- All fellows receive training in research methodologies related to multiple sclerosis (MS) under the mentorship of professionals.
- In addition, fellows have the opportunity to work in a European laboratory or clinic. Hence, promoting international collaboration and exposure to diverse research environments.
- The fellowship exchange program 2025 encourages fellows to present their research findings at annual ECTRIMS congresses. Thus, providing a platform to showcase their work.
- ECTRIMS fellows will get a chance to engage with the global multiple sclerosis (MS) research community.
- Through the ECTRIMS Research Training Fellowship Programme, fellows will get to experience cultural diversity through exposure to different cultures within Europe and the chance to study in Switzerland.
ELIGIBILITY
The eligibility criteria for the Fully Funded ECTRIMS Research Fellowship in Switzerland are stated below:
- The ECTRIMS Fellowship Program is open to scientists and physicians of any nationality holding an MD, PhD, ScD, or equivalent qualification.
- Citizens from any country are eligible to apply. However, the research training itself must be conducted in a European laboratory or clinic.
- Candidates must have an interest in research training revolving around multiple sclerosis (MS).
- Similarly, research topics must be directly related to MS, spanning its various specialties and fields.
- Candidates must have obtained their advanced degree(s) before starting this European fellowship.
- Moreover, at the time of application, fellows should not have more than 12 months of previous postdoctoral training at the same host institution or under the same mentor.
- For senior candidates, the overall postdoctoral experience should not exceed five years beyond their final degree (PhD, MD, ScD, or equivalent).
- Successful applicants, in general, should be under 40 years of age at the time of application. However, there may be exceptions under special circumstances.
- Language proficiency is an essential requirement of the ECTRIMS Research Training Fellowship Programme. Both candidates and mentors must confirm that there will be no language barriers hindering the training experience.
- European citizens applying for the ECTRIMS fellowship 2025 should select a laboratory or clinic situated in a European country different from their own citizenship.
OTHERS
Documents Required for ECTRIMS Fellowship in Switzerland:
- Curriculum Vitae (CV) and bibliography
- Career Plan (maximum 1 page)
- Abstract/Research project summary (no more than 250 words)
- Research project description (maximum 6 pages)
- Proof of language proficiency (local language of the training venue)
Kindly Note
All Jobs and Opportunities Published on mucuruzi.com are completely free to apply. A candidate should never pay any fee during the recruitment Process. Even if mucuruzi.com does its best to avoid any scam job or opportunity offer, a job seeker or an opportunity seeker is 100% responsible of applying at his own risk.
Check well before applying, if you doubt about the eligibility of any offer do not apply and notifie to mucuruzi.com via this email: mucuruzi2016@gmail.com and remember to never pay any fee to have a job or get any opportunity, if you do so, do it at your own risk.